Bill to Lower Drug Prices Gains Bipartisan Momentum in the House and Senate
Stakeholders Support Legislation That Will Stop Brand Drug Companies From Blocking Access to Affordable Generic Drugs WASHINGTON, DC (April 27, 2017) – The Association for
Stakeholders Support Legislation That Will Stop Brand Drug Companies From Blocking Access to Affordable Generic Drugs WASHINGTON, DC (April 27, 2017) – The Association for
The National Health Council Supports Generic Drugs as a Way to Reduce Health Care Costs WASHINGTON, DC (April 27, 2017) – The Association for Accessible
Governor Hogan Should Veto Legislation To Keep Generic Drugs Affordable for Maryland WASHINGTON, DC (April 10, 2017) Generic drugs have been and continue to be
Health Care Groups Also Back New Bill to Ensure Access at Lower Costs WASHINGTON, DC (April 7, 2017) – The Association for Accessible Medicines (AAM)
Statement of Chester “Chip” Davis Jr., President and CEO of the Association for Accessible Medicines on the Confirmation of Seema Verma as Administrator of the
Statement of Chester “Chip” Davis Jr., President and CEO of the Association for Accessible Medicines on the Nomination of Dr. Scott Gottlieb as Commissioner of
Generic Pharmaceutical Association Becomes Association for Accessible Medicines Education Campaign Reinforces Generics Reduce Drug Costs, Drive Savings (Feb. 14, 2017) — The Generic Pharmaceutical Association,
WASHINGTON, DC (February 10, 2017) – “We congratulate Secretary Price on today’s confirmation and look forward to working with his team, President Trump and both
WASHINGTON, DC (January 18, 2017) — “Congressman Price has a deep background and expertise in complicated health care issues and has been a leader in
WASHINGTON DC (Jan. 11, 2017) – “We understand the President-Elect’s concerns about drug prices. Patients and drug purchasers like the federal government, health systems, employers
